| 1 |
Differential benefits of olanzapine on executive function in schizophrenia patients: Preliminary findings |
|
| | Neeti D. Mehta,Michelle J. Won,Shelly L. Babin,Saumil S. Patel,Adel A. Wassef,Alice Z. Chuang,Anne B. Sereno | | | Human Psychopharmacology: Clinical and Experimental. 2019; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia |
|
| | Hannah E. Brown,Oliver Freudenreich,Xiaoduo Fan,Stephen O. Heard,Donald Goff,George Petrides,Amy L. Harrington,John M. Kane,Heidi Judge,Bettina Hoeppner,Maurizio Fava,Roy H. Perlis | | | JAMA Psychiatry. 2019; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
A case report of guardian-consent forced paliperidone palmitate for behavioral disturbance due to traumatic brain injury |
|
| | Amber R. Douglass,Uyen Smyth | | | Mental Health Clinician. 2018; 8(3): 155 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Experiences of Family Carers for Persons Using Antipsychotic Medication |
|
| | Paul Morrison,Norman Stomski | | | Australian and New Zealand Journal of Family Therapy. 2017; 38(3): 498 | | | [Pubmed] [Google Scholar] [DOI] | |
|
